Scinovex
article Open AccessTop 1% cited

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

Diabetes Care · 2004 · Vol. 27(1) · pp. 155–161
Jarl TorgersonJonathan HauptmanMark BoldrinLars Sjöström

Abstract

Compared with lifestyle changes alone, orlistat plus lifestyle changes resulted in a greater reduction in the incidence of type 2 diabetes over 4 years and produced greater weight loss in a clinically representative obese population. Difference in diabetes incidence was detectable only in the IGT subgroup; weight loss was similar in subjects with IGT or NGT [correction].

Pharmacology and Obesity TreatmentDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerOrlistatMedicineOverweightPlaceboDiabetes mellitusInternal medicineImpaired glucose toleranceType 2 diabetesWeight lossIncidence (geometry)

MeSH terms

OrlistatAdultEnergy IntakeDiabetes MellitusDouble-Blind MethodFemaleGlucose Tolerance TestHumansLactonesLife StyleLipaseMaleMiddle AgedObesityPlacebos
Citations
1,885
FWCI
98.89
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study · Scinovex